Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Frederic Olbrechts"'
Publikováno v:
European Journal of Case Reports in Internal Medicine (2022)
Dasatanib is a second-generation tyrosine kinase inhibitor with activity on the BCR-ABL fusion gene. it is used in the treatment of BCR-ABL positive chronic myeloid leukaemia and has the known side effect of pleural effusion. This usually involves ex
Externí odkaz:
https://doaj.org/article/6e2062f56e844b61a4c22fbc634a4408
Publikováno v:
European Journal of Case Reports in Internal Medicine.
Dasatinib is a second-generation tyrosine kinase inhibitor with activity on the BCR-ABL fusion gene. It is used in the treatment of BCR-ABL positive chronic myeloid leukaemia and has the known side effect of pleural effusion. This usually involves ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef322a94f934acddd7654cf7890ec879
https://doi.org/10.12890/2022_003601
https://doi.org/10.12890/2022_003601